微信小陈
微信小章| 产品名称： | Lipomyces starkeyi Lodder et Kreger-van Rij |
|---|---|
| 商品货号： | TS145740 |
| Strain Designations： | CMK-1 |
| Application： | produces dextranase produces clinical dextran by mixed-culture fermentation with Leuconostoc mesenteroides subsp. mesenteroides ATCC 10830 |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | frozen |
| Storage Conditions： | Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section |
| Type Strain： | no |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®： | no |
| Medium： | ATCC® Medium 28: Emmons modification of Sabourauds agar |
| Growth Conditions： | Temperature: 26.0°C |
| Name of Depositor： | Louisiana St. Univ. |
| U.S. Patent Number： | |
| Special Collection： | NCRR Contract |
| Isolation： | mutant derived from ATCC 12659 |
| References： | Kim D, Day DF. A new process for the production of clinical dextran by mixed-culture fermentation of Lipomyces starkeyi and Leuconostoc mesenteroides. Enzyme Microb. Technol. 16: 844-848, 1994. PubMed: 7521648 Day DF, Kim D. Process for the production of dextran polymers of controlled molecular size and molecular size distributions. US Patent 5,229,277 dated Jul 20 1993 Kim D, Day DF. Isolation of a dextranase constitutive mutant of Lipomyces starkeyi and its use for the production of clinical size dextran. Lett. Appl. Microbiol. 20: 268-270, 1995. PubMed: 7766225 |